H Kemona
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 30
- Inflammatory Biomarkers in Disease Prognosis 23
- Peptidase Inhibition and Analysis 3
- Hematology 12
- Platelet Disorders and Treatments 10
- Co-authors
- Violetta Dymicka-Piekarska (35 shared papers)Joanna Kamińska (14 shared papers)Olga Martyna Koper‐Lenkiewicz (13 shared papers)Joanna Matowicka-Karna (40 shared papers)Piotr Radziwon (2 shared papers)J Prokopowicz (18 shared papers)Joanna Osada (2 shared papers)Katarzyna Guzińska-Ustymowicz (2 shared papers)
In The Last Decade
H Kemona
92 papers receiving 1.9k citations
H Kemona's Hit Papers
Peers
Comparison fields: 5 of 128
- Internal Medicine 80
- Oncology 584
- Parasitology 133
- Hematology 153
- Immunology 242
Countries citing papers authored by H Kemona
This map shows the geographic impact of H Kemona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Kemona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Kemona more than expected).
Fields of papers citing papers by H Kemona
This network shows the impact of papers produced by H Kemona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Kemona. The network helps show where H Kemona may publish in the future.
Co-authors
The 25 scholars most cited alongside H Kemona, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions Hit paper breakdown → | 2019 | 381 |
| 2 | 2016 | 212 | |
| 3 | 2018 | 153 | |
| 4 | 2017 | 84 | |
| 5 | 2005 | 81 | |
| 6 | 2009 | 68 | |
| 7 | 2013 | 56 | |
| 8 | 2011 | 51 | |
| 9 | 2014 | 49 | |
| 10 | 2016 | 47 | |
| 11 | 2009 | 45 | |
| 12 | 2011 | 44 | |
| 13 | 2015 | 35 | |
| 14 | 2009 | 34 | |
| 15 | 2006 | 34 | |
| 16 | Does smoking affect thrombocytopoiesis and platelet activation in women and men? | 2006 | 28 |
| 17 | 2011 | 28 | |
| 18 | [The cytokines in inflammatory bowel disease]. | 2009 | 28 |
| 19 | 2009 | 21 | |
| 20 | Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer. | 2003 | 21 |
About H Kemona
H Kemona is a scholar working on Oncology, Hematology, Surgery, Immunology and Allergy and Parasitology, having authored 94 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (23 papers), Platelet Disorders and Treatments (10 papers), Cell Adhesion Molecules Research (9 papers), Toxoplasma gondii Research Studies (6 papers), Parasitic Infections and Diagnostics (3 papers), Peptidase Inhibition and Analysis (3 papers), Parasitic infections in humans and animals (3 papers) and Inflammatory Bowel Disease (3 papers). The work is most often cited by research in Internal Medicine (80 citations), Oncology (584 citations), Parasitology (133 citations), Hematology (153 citations) and Immunology (242 citations). H Kemona has collaborated with scholars based in Poland, Germany and Austria. Frequent co-authors include Violetta Dymicka-Piekarska, Joanna Kamińska, Olga Martyna Koper‐Lenkiewicz, Joanna Matowicka-Karna, Piotr Radziwon, J Prokopowicz, Joanna Osada, Katarzyna Guzińska-Ustymowicz, Jerzy Bychowski and Mariusz Gryko. Their work appears in journals such as Thrombosis Research, Platelets, Oncotarget, BMC Oral Health and The International Journal of Biological Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.